Different Contribution of Apoptosis to the Antiproliferative Effects of L-Arginine, Enalapril and Losartan on Neointimal Growth Inhibition After Balloon Arterial Injury

It remains to be clarified how angiotensin-converting enzyme inhibitor-induced function (ie, increased NO related action or the inhibition of angiotensin II AT1 receptor dependent action) affects apoptosis of smooth muscle cells in the neointima following arterial injury. Saline (control), enalapril...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation Journal 2002, Vol.66(10), pp.965-971
Hauptverfasser: Ohwada, Takayuki, Ishibashi, Toshiyuki, Yaoita, Hiroyuki, Shindo, Joji, Noji, Hideyoshi, Ohkawara, Hiroyuki, Sugimoto, Kouichi, Sakamoto, Takayuki, Maehara, Kazuhira, Maruyama, Yukio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 971
container_issue 10
container_start_page 965
container_title Circulation Journal
container_volume 66
creator Ohwada, Takayuki
Ishibashi, Toshiyuki
Yaoita, Hiroyuki
Shindo, Joji
Noji, Hideyoshi
Ohkawara, Hiroyuki
Sugimoto, Kouichi
Sakamoto, Takayuki
Maehara, Kazuhira
Maruyama, Yukio
description It remains to be clarified how angiotensin-converting enzyme inhibitor-induced function (ie, increased NO related action or the inhibition of angiotensin II AT1 receptor dependent action) affects apoptosis of smooth muscle cells in the neointima following arterial injury. Saline (control), enalapril, L-arginine, combined enalapril and L-arginine, or losartan was administered for 14 days to Sprague-Dawley rats after balloon carotid injury and the ratio of intima to media areas (I/M), inducible NO synthase (iNOS) concentrations and %TUNEL were measured. I/M decreased similarly in the enalapril, L-arginine and losartan groups, and the combination of enalapril and L-arginine resulted in the largest I/M decrease. TUNEL positivity was increased compared with controls in the following order: losartan, L-arginine, enalapril and combination of enalapril and L-arginine. The intensity of immunostaining for iNOS was increased approximately 1.9-fold compared with the control in the combined enarapril and L-arginine group as well as in the enalapril group. These data suggest that the apoptosis in the neointima is different for L-arginine, losartan and enalapril under similar conditions and was higher under treatment with enalapril, not only via the action of NO or blocking of the AT1, but also by upregulation of iNOS. (Circ J 2002; 66: 965 - 971)
doi_str_mv 10.1253/circj.66.965
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72184380</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72184380</sourcerecordid><originalsourceid>FETCH-LOGICAL-c608t-64d2e6ffa1bf6943b14004b9855f9aecea53aaba0f703a05121931913b91f4d83</originalsourceid><addsrcrecordid>eNpFkU2P0zAQhiMEYpeFG2fkC5w2xY4dNz6GUpZKFVzgHE3c8daVaxfbAe0_4mfifohebI_8zDsfb1W9ZXTGmpZ_1Dbq3UzKmZLts-qWcTGvRdfQ56e3rFUn-E31KqUdpY2irXpZ3bCGd4wqcVv9_WyNwYg-k0XwOdpxyjZ4EgzpD-GQQ7KJ5EDyFknvsz3E4GxJgGx_I1mWXJ3TkV7XfXy03nq8J0sPDg7ROgJ-Q9YhQcxQND35hsEWlT048hDDn7wlK7-1oz3V7E3GSD6Bc-EYxRLZAq78bopPr6sXBlzCN5f7rvr5Zflj8bVef39YLfp1rSXtci3FpkFpDLDRSCX4yASlYlRd2xoFqBFaDjACNXPKgbasYYozxfiomBGbjt9VH866ZdJfE6Y87G3S6Bx4DFMa5g0rC-1oAe_PoI4hpYhmKBPvIT4NjA5HZ4aTM4OUQ3Gm4O8uutO4x80VvlhRgPcXAJIGZyJ4bdOVE6wMIVnhFmdulzI84n-g7Nhqh9eqpY3zWcpff7cQB_T8H1cVsrc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72184380</pqid></control><display><type>article</type><title>Different Contribution of Apoptosis to the Antiproliferative Effects of L-Arginine, Enalapril and Losartan on Neointimal Growth Inhibition After Balloon Arterial Injury</title><source>J-STAGE Free</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Ohwada, Takayuki ; Ishibashi, Toshiyuki ; Yaoita, Hiroyuki ; Shindo, Joji ; Noji, Hideyoshi ; Ohkawara, Hiroyuki ; Sugimoto, Kouichi ; Sakamoto, Takayuki ; Maehara, Kazuhira ; Maruyama, Yukio</creator><creatorcontrib>Ohwada, Takayuki ; Ishibashi, Toshiyuki ; Yaoita, Hiroyuki ; Shindo, Joji ; Noji, Hideyoshi ; Ohkawara, Hiroyuki ; Sugimoto, Kouichi ; Sakamoto, Takayuki ; Maehara, Kazuhira ; Maruyama, Yukio</creatorcontrib><description>It remains to be clarified how angiotensin-converting enzyme inhibitor-induced function (ie, increased NO related action or the inhibition of angiotensin II AT1 receptor dependent action) affects apoptosis of smooth muscle cells in the neointima following arterial injury. Saline (control), enalapril, L-arginine, combined enalapril and L-arginine, or losartan was administered for 14 days to Sprague-Dawley rats after balloon carotid injury and the ratio of intima to media areas (I/M), inducible NO synthase (iNOS) concentrations and %TUNEL were measured. I/M decreased similarly in the enalapril, L-arginine and losartan groups, and the combination of enalapril and L-arginine resulted in the largest I/M decrease. TUNEL positivity was increased compared with controls in the following order: losartan, L-arginine, enalapril and combination of enalapril and L-arginine. The intensity of immunostaining for iNOS was increased approximately 1.9-fold compared with the control in the combined enarapril and L-arginine group as well as in the enalapril group. These data suggest that the apoptosis in the neointima is different for L-arginine, losartan and enalapril under similar conditions and was higher under treatment with enalapril, not only via the action of NO or blocking of the AT1, but also by upregulation of iNOS. (Circ J 2002; 66: 965 - 971)</description><identifier>ISSN: 1346-9843</identifier><identifier>EISSN: 1347-4820</identifier><identifier>DOI: 10.1253/circj.66.965</identifier><identifier>PMID: 12381094</identifier><language>eng</language><publisher>Kyoto: The Japanese Circulation Society</publisher><subject>ACE inhibitor ; Angiotensin-Converting Enzyme Inhibitors - pharmacology ; Animals ; Apoptosis ; Apoptosis - drug effects ; Arginine - pharmacology ; Atherosclerosis ; Biological and medical sciences ; Carotid Artery Injuries - drug therapy ; Carotid Artery Injuries - etiology ; Catheterization - adverse effects ; Cell Division - drug effects ; Diseases of the cardiovascular system ; Enalapril - pharmacology ; Graft Occlusion, Vascular - drug therapy ; Losartan - pharmacology ; Male ; Medical sciences ; Muscle, Smooth, Vascular - drug effects ; Muscle, Smooth, Vascular - enzymology ; Muscle, Smooth, Vascular - pathology ; Nitric oxide ; Nitric Oxide Synthase - biosynthesis ; Nitric Oxide Synthase - drug effects ; Nitric Oxide Synthase Type II ; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) ; Rats ; Rats, Sprague-Dawley ; Restenosis ; Up-Regulation - drug effects</subject><ispartof>Circulation Journal, 2002, Vol.66(10), pp.965-971</ispartof><rights>2002 THE JAPANESE CIRCULATION SOCIETY</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c608t-64d2e6ffa1bf6943b14004b9855f9aecea53aaba0f703a05121931913b91f4d83</citedby><cites>FETCH-LOGICAL-c608t-64d2e6ffa1bf6943b14004b9855f9aecea53aaba0f703a05121931913b91f4d83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14198561$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12381094$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ohwada, Takayuki</creatorcontrib><creatorcontrib>Ishibashi, Toshiyuki</creatorcontrib><creatorcontrib>Yaoita, Hiroyuki</creatorcontrib><creatorcontrib>Shindo, Joji</creatorcontrib><creatorcontrib>Noji, Hideyoshi</creatorcontrib><creatorcontrib>Ohkawara, Hiroyuki</creatorcontrib><creatorcontrib>Sugimoto, Kouichi</creatorcontrib><creatorcontrib>Sakamoto, Takayuki</creatorcontrib><creatorcontrib>Maehara, Kazuhira</creatorcontrib><creatorcontrib>Maruyama, Yukio</creatorcontrib><title>Different Contribution of Apoptosis to the Antiproliferative Effects of L-Arginine, Enalapril and Losartan on Neointimal Growth Inhibition After Balloon Arterial Injury</title><title>Circulation Journal</title><addtitle>Circ J</addtitle><description>It remains to be clarified how angiotensin-converting enzyme inhibitor-induced function (ie, increased NO related action or the inhibition of angiotensin II AT1 receptor dependent action) affects apoptosis of smooth muscle cells in the neointima following arterial injury. Saline (control), enalapril, L-arginine, combined enalapril and L-arginine, or losartan was administered for 14 days to Sprague-Dawley rats after balloon carotid injury and the ratio of intima to media areas (I/M), inducible NO synthase (iNOS) concentrations and %TUNEL were measured. I/M decreased similarly in the enalapril, L-arginine and losartan groups, and the combination of enalapril and L-arginine resulted in the largest I/M decrease. TUNEL positivity was increased compared with controls in the following order: losartan, L-arginine, enalapril and combination of enalapril and L-arginine. The intensity of immunostaining for iNOS was increased approximately 1.9-fold compared with the control in the combined enarapril and L-arginine group as well as in the enalapril group. These data suggest that the apoptosis in the neointima is different for L-arginine, losartan and enalapril under similar conditions and was higher under treatment with enalapril, not only via the action of NO or blocking of the AT1, but also by upregulation of iNOS. (Circ J 2002; 66: 965 - 971)</description><subject>ACE inhibitor</subject><subject>Angiotensin-Converting Enzyme Inhibitors - pharmacology</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Arginine - pharmacology</subject><subject>Atherosclerosis</subject><subject>Biological and medical sciences</subject><subject>Carotid Artery Injuries - drug therapy</subject><subject>Carotid Artery Injuries - etiology</subject><subject>Catheterization - adverse effects</subject><subject>Cell Division - drug effects</subject><subject>Diseases of the cardiovascular system</subject><subject>Enalapril - pharmacology</subject><subject>Graft Occlusion, Vascular - drug therapy</subject><subject>Losartan - pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Muscle, Smooth, Vascular - drug effects</subject><subject>Muscle, Smooth, Vascular - enzymology</subject><subject>Muscle, Smooth, Vascular - pathology</subject><subject>Nitric oxide</subject><subject>Nitric Oxide Synthase - biosynthesis</subject><subject>Nitric Oxide Synthase - drug effects</subject><subject>Nitric Oxide Synthase Type II</subject><subject>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Restenosis</subject><subject>Up-Regulation - drug effects</subject><issn>1346-9843</issn><issn>1347-4820</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkU2P0zAQhiMEYpeFG2fkC5w2xY4dNz6GUpZKFVzgHE3c8daVaxfbAe0_4mfifohebI_8zDsfb1W9ZXTGmpZ_1Dbq3UzKmZLts-qWcTGvRdfQ56e3rFUn-E31KqUdpY2irXpZ3bCGd4wqcVv9_WyNwYg-k0XwOdpxyjZ4EgzpD-GQQ7KJ5EDyFknvsz3E4GxJgGx_I1mWXJ3TkV7XfXy03nq8J0sPDg7ROgJ-Q9YhQcxQND35hsEWlT048hDDn7wlK7-1oz3V7E3GSD6Bc-EYxRLZAq78bopPr6sXBlzCN5f7rvr5Zflj8bVef39YLfp1rSXtci3FpkFpDLDRSCX4yASlYlRd2xoFqBFaDjACNXPKgbasYYozxfiomBGbjt9VH866ZdJfE6Y87G3S6Bx4DFMa5g0rC-1oAe_PoI4hpYhmKBPvIT4NjA5HZ4aTM4OUQ3Gm4O8uutO4x80VvlhRgPcXAJIGZyJ4bdOVE6wMIVnhFmdulzI84n-g7Nhqh9eqpY3zWcpff7cQB_T8H1cVsrc</recordid><startdate>2002</startdate><enddate>2002</enddate><creator>Ohwada, Takayuki</creator><creator>Ishibashi, Toshiyuki</creator><creator>Yaoita, Hiroyuki</creator><creator>Shindo, Joji</creator><creator>Noji, Hideyoshi</creator><creator>Ohkawara, Hiroyuki</creator><creator>Sugimoto, Kouichi</creator><creator>Sakamoto, Takayuki</creator><creator>Maehara, Kazuhira</creator><creator>Maruyama, Yukio</creator><general>The Japanese Circulation Society</general><general>Japanese Circulation Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2002</creationdate><title>Different Contribution of Apoptosis to the Antiproliferative Effects of L-Arginine, Enalapril and Losartan on Neointimal Growth Inhibition After Balloon Arterial Injury</title><author>Ohwada, Takayuki ; Ishibashi, Toshiyuki ; Yaoita, Hiroyuki ; Shindo, Joji ; Noji, Hideyoshi ; Ohkawara, Hiroyuki ; Sugimoto, Kouichi ; Sakamoto, Takayuki ; Maehara, Kazuhira ; Maruyama, Yukio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c608t-64d2e6ffa1bf6943b14004b9855f9aecea53aaba0f703a05121931913b91f4d83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>ACE inhibitor</topic><topic>Angiotensin-Converting Enzyme Inhibitors - pharmacology</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Arginine - pharmacology</topic><topic>Atherosclerosis</topic><topic>Biological and medical sciences</topic><topic>Carotid Artery Injuries - drug therapy</topic><topic>Carotid Artery Injuries - etiology</topic><topic>Catheterization - adverse effects</topic><topic>Cell Division - drug effects</topic><topic>Diseases of the cardiovascular system</topic><topic>Enalapril - pharmacology</topic><topic>Graft Occlusion, Vascular - drug therapy</topic><topic>Losartan - pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Muscle, Smooth, Vascular - drug effects</topic><topic>Muscle, Smooth, Vascular - enzymology</topic><topic>Muscle, Smooth, Vascular - pathology</topic><topic>Nitric oxide</topic><topic>Nitric Oxide Synthase - biosynthesis</topic><topic>Nitric Oxide Synthase - drug effects</topic><topic>Nitric Oxide Synthase Type II</topic><topic>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Restenosis</topic><topic>Up-Regulation - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ohwada, Takayuki</creatorcontrib><creatorcontrib>Ishibashi, Toshiyuki</creatorcontrib><creatorcontrib>Yaoita, Hiroyuki</creatorcontrib><creatorcontrib>Shindo, Joji</creatorcontrib><creatorcontrib>Noji, Hideyoshi</creatorcontrib><creatorcontrib>Ohkawara, Hiroyuki</creatorcontrib><creatorcontrib>Sugimoto, Kouichi</creatorcontrib><creatorcontrib>Sakamoto, Takayuki</creatorcontrib><creatorcontrib>Maehara, Kazuhira</creatorcontrib><creatorcontrib>Maruyama, Yukio</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ohwada, Takayuki</au><au>Ishibashi, Toshiyuki</au><au>Yaoita, Hiroyuki</au><au>Shindo, Joji</au><au>Noji, Hideyoshi</au><au>Ohkawara, Hiroyuki</au><au>Sugimoto, Kouichi</au><au>Sakamoto, Takayuki</au><au>Maehara, Kazuhira</au><au>Maruyama, Yukio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Different Contribution of Apoptosis to the Antiproliferative Effects of L-Arginine, Enalapril and Losartan on Neointimal Growth Inhibition After Balloon Arterial Injury</atitle><jtitle>Circulation Journal</jtitle><addtitle>Circ J</addtitle><date>2002</date><risdate>2002</risdate><volume>66</volume><issue>10</issue><spage>965</spage><epage>971</epage><pages>965-971</pages><issn>1346-9843</issn><eissn>1347-4820</eissn><abstract>It remains to be clarified how angiotensin-converting enzyme inhibitor-induced function (ie, increased NO related action or the inhibition of angiotensin II AT1 receptor dependent action) affects apoptosis of smooth muscle cells in the neointima following arterial injury. Saline (control), enalapril, L-arginine, combined enalapril and L-arginine, or losartan was administered for 14 days to Sprague-Dawley rats after balloon carotid injury and the ratio of intima to media areas (I/M), inducible NO synthase (iNOS) concentrations and %TUNEL were measured. I/M decreased similarly in the enalapril, L-arginine and losartan groups, and the combination of enalapril and L-arginine resulted in the largest I/M decrease. TUNEL positivity was increased compared with controls in the following order: losartan, L-arginine, enalapril and combination of enalapril and L-arginine. The intensity of immunostaining for iNOS was increased approximately 1.9-fold compared with the control in the combined enarapril and L-arginine group as well as in the enalapril group. These data suggest that the apoptosis in the neointima is different for L-arginine, losartan and enalapril under similar conditions and was higher under treatment with enalapril, not only via the action of NO or blocking of the AT1, but also by upregulation of iNOS. (Circ J 2002; 66: 965 - 971)</abstract><cop>Kyoto</cop><pub>The Japanese Circulation Society</pub><pmid>12381094</pmid><doi>10.1253/circj.66.965</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1346-9843
ispartof Circulation Journal, 2002, Vol.66(10), pp.965-971
issn 1346-9843
1347-4820
language eng
recordid cdi_proquest_miscellaneous_72184380
source J-STAGE Free; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects ACE inhibitor
Angiotensin-Converting Enzyme Inhibitors - pharmacology
Animals
Apoptosis
Apoptosis - drug effects
Arginine - pharmacology
Atherosclerosis
Biological and medical sciences
Carotid Artery Injuries - drug therapy
Carotid Artery Injuries - etiology
Catheterization - adverse effects
Cell Division - drug effects
Diseases of the cardiovascular system
Enalapril - pharmacology
Graft Occlusion, Vascular - drug therapy
Losartan - pharmacology
Male
Medical sciences
Muscle, Smooth, Vascular - drug effects
Muscle, Smooth, Vascular - enzymology
Muscle, Smooth, Vascular - pathology
Nitric oxide
Nitric Oxide Synthase - biosynthesis
Nitric Oxide Synthase - drug effects
Nitric Oxide Synthase Type II
Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)
Rats
Rats, Sprague-Dawley
Restenosis
Up-Regulation - drug effects
title Different Contribution of Apoptosis to the Antiproliferative Effects of L-Arginine, Enalapril and Losartan on Neointimal Growth Inhibition After Balloon Arterial Injury
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T00%3A53%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Different%20Contribution%20of%20Apoptosis%20to%20the%20Antiproliferative%20Effects%20of%20L-Arginine,%20Enalapril%20and%20Losartan%20on%20Neointimal%20Growth%20Inhibition%20After%20Balloon%20Arterial%20Injury&rft.jtitle=Circulation%20Journal&rft.au=Ohwada,%20Takayuki&rft.date=2002&rft.volume=66&rft.issue=10&rft.spage=965&rft.epage=971&rft.pages=965-971&rft.issn=1346-9843&rft.eissn=1347-4820&rft_id=info:doi/10.1253/circj.66.965&rft_dat=%3Cproquest_cross%3E72184380%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72184380&rft_id=info:pmid/12381094&rfr_iscdi=true